Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by juniper88

T.TH

RE:Avatar Challenge

I am up to the challenge. Reina is the black cat my daughter and I adopted on...

10 days ago

T.TH

RE:RE:RE:RE:They delivered on their follow-ups

Personally, I believe these are good result.  In my opinion, POC was met...

13 days ago

T.TH

RE:RE:RE:RE:New Press Release - Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada

For #1, it is a provincial jurisdiction.  They need to negotiate with...

December 4, 2024

T.TH

RE:RE:New Press Release - Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada

$10 million US upfront???  Plus more milestone payments and double digit...

December 4, 2024

T.TH

RE:$30/Share

I am in a similar situation but my cost base is much lower.  Either way...

September 25, 2024

T.TH

Interest with Marathon

This is a question for posters like Palinc who know about this financing a...

September 20, 2024

T.TH

RE:Do we have any anecdotal information?

I am sorry for your loss.  And the loss is yours and your family as he...

July 25, 2024

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Murky sales report imo

I kinda take everything that management says with a grain of salt.  As I...

July 15, 2024

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:Murky sales report imo

So, if the new normal quarterly sales base was $16.2 million last quarter...

July 14, 2024

T.TH

RE:RE:RE:RE:RE:RE:Murky sales report imo

The math is simple, I don't believe anyone needs to check it.  ...

July 12, 2024

T.TH

RE:RE:RE:Murky sales report imo

Mannequin wrote: What's the issue fellas? They reaffirmed guidance. ...

July 11, 2024

T.TH

RE:Murky sales report imo

How is this different from any other quarterly report in the last 10 years...

July 10, 2024

T.TH

RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

The biomarker for ovarian cancer is CA-125. With my wife after 1 infusion of...

May 26, 2024

T.TH

RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

I won't pretend to know the science as qwerty or scarlett would know...

May 23, 2024

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I don't know what it takes

I feel this year we have the freedom to vote our conscience without having to...

April 25, 2024

T.TH

RE:RE:RE:RE:RE:Voting for AGM

I have similar thoughts.   Any thoughts on what might be an...

March 27, 2024

T.TH

RE:RE:RE:Voting for AGM

PWIB123 and Manequin I am on the same page with both of you on this. One...

March 27, 2024

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

QWERTY, I agree with what you are saying and I certainly hope for some PR...

March 23, 2024

T.TH

RE:RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

The biggest help for ovarian cancer patients in the last couple of years have...

March 22, 2024

T.TH

RE:RE:RE:RE:RE:RE: PLWH and Nash

"(which they didn't) "  QWERTY, that is just your...

March 15, 2024

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Mullen Group Ltd.

Mullen Group Ltd. T.MTL

Mullen Group is one of North America's largest logistics providers with a network of independently operated businesses ... view more »